Immunologic trials for
identification of
HIV (HTLV-III/lav) antibodies. They include assays for
HIV seropositivity and
HIV seronegativity (elisa, immunofluorescence, immunoblot, etc.) that have been developed for
screening persons carrying the
viral antibody from
patients with overt symptoms of aids or aids-related composite.